John D. Reveille

John D. Reveille's AcademicInfluence.com Rankings

John D. Reveille

Medical

#1574

World Rank

#1926

Historical Rank

Rheumatology

World Rank

Historical Rank

medical Degrees

Download Badge

Medical

Why Is John D. Reveille Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John D. Reveille's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. (2008) (3437)
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants (2007) (1421)
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis (2017) (1140)
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility (2011) (807)
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus (2009) (782)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. (2006) (779)
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci (2013) (689)
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci (2010) (639)
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force (2013) (436)
Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. (2000) (424)
The impact of tumor necrosis factor α inhibitors on radiographic progression in ankylosing spondylitis. (2013) (422)
Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L) (2007) (421)
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (2016) (405)
Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. (2014) (339)
Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. (2005) (333)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events. (2004) (333)
Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis (2002) (332)
Human polymorphism at microRNAs and microRNA target sites. (2013) (330)
Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. (2008) (324)
The clinical relevance of autoantibodies in scleroderma (2003) (307)
Genetics of systemic lupus erythematosus. (1992) (305)
Prognosis in systemic lupus erythematosus (1990) (300)
Systemic lupus erythematosus in three ethnic groups. VIII. Predictors of early mortality in the LUMINA cohort (2001) (298)
Radiographic assessment and psychologic variables as predictors of pain and functional impairment in osteoarthritis of the knee or hip. (1988) (284)
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus (2011) (267)
Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. (2001) (263)
Transancestral mapping and genetic load in systemic lupus erythematosus (2017) (253)
Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies. (2003) (252)
Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort (2006) (245)
Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. (2001) (243)
A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. (2007) (242)
Gene and pathway-based second-wave analysis of genome-wide association studies (2010) (238)
Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. (1996) (237)
Baseline characteristics of a multiethnic lupus cohort: PROFILE (2002) (227)
Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. (2009) (226)
End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1 (2014) (226)
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset (1998) (225)
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1 (2015) (214)
Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease (2010) (209)
Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course (1998) (195)
Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility (2011) (193)
Prevalence of axial spondylarthritis in the United States: Estimates from a cross‐sectional survey (2012) (190)
The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease (2007) (189)
Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. (2008) (185)
Systemic sclerosis and lupus: points in an interferon-mediated continuum. (2010) (178)
Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. (2014) (177)
Genetics of spondyloarthritis—beyond the MHC (2012) (174)
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls (2009) (173)
Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. (2007) (172)
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. (1996) (169)
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and (2018) (168)
Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course. (2004) (165)
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. (1996) (163)
Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 Allelic Profiles Distinguish European American Patients With Different Myositis Autoantibodies (2006) (162)
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. (2012) (159)
Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. (1996) (157)
Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. (1990) (156)
The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. (2004) (154)
Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. (2003) (154)
HLA-B27 and genetic predisposing factors in spondyloarthropathies (2001) (152)
Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort. (2007) (151)
Evidence that autoimmunity in man is a Mendelian dominant trait. (1986) (147)
Specific amino acid residues in the second hypervariable region of HLA-DQA1 and DQB1 chain genes promote the Ro (SS-A)/La (SS-B) autoantibody responses. (1991) (147)
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations (2009) (145)
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort (2010) (145)
The Epidemiology of Back Pain, Axial Spondyloarthritis and HLA-B27 in the United States (2013) (144)
Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS (2013) (139)
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. (2010) (139)
Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time (2006) (138)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. (2005) (137)
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus (2011) (135)
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis (2007) (135)
Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis (2000) (134)
Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. (1993) (133)
Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. (2005) (133)
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. (2007) (133)
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis (2009) (132)
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). (1992) (132)
Spondyloarthritis: update on pathogenesis and management. (2005) (131)
Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. (1999) (131)
Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection. (2004) (129)
Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. (2006) (128)
The diffuse infiltrative lymphocytosis syndrome: clinical and immunogenetic features in 35 patients (1996) (125)
Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. (2009) (125)
Genetic studies in familial ankylosing spondylitis susceptibility. (2004) (123)
Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. (2009) (123)
The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009. (2012) (123)
PREDICTING INDIVIDUAL DIFFERENCES IN PAIN AND FUNCTIONAL IMPAIRMENT AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (1989) (123)
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors (2019) (123)
Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events. (2005) (122)
Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. (2001) (122)
Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus (2008) (122)
A polymorphism within IL21R confers risk for systemic lupus erythematosus. (2009) (121)
Predictive value of autoantibodies for activity of systemic lupus erythematosus (2004) (121)
Molecular analysis of major histocompatibility complex alleles associated with the lupus anticoagulant. (1991) (120)
Major histocompatibility genes and ankylosing spondylitis. (2006) (119)
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. (2011) (119)
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus (2011) (117)
Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage. (2003) (116)
Systemic lupus erythematosus in a multiethnic US cohort: Clinical features, course, and outcome in patients with late‐onset disease (2006) (115)
Association of an ERAP1 ERAP2 haplotype with familial ankylosing spondylitis (2009) (115)
Clinical and genetic factors predictive of mortality in early systemic sclerosis. (2009) (113)
HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. (2009) (113)
Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. (2003) (112)
Genetic Dissection of Acute Anterior Uveitis Reveals Similarities and Differences in Associations Observed With Ankylosing Spondylitis (2015) (112)
Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. (1998) (109)
BANK1 functional variants are associated with susceptibility to diffuse systemic sclerosis in Caucasians (2009) (108)
Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. (1984) (108)
Autoantibody responses to the "native" 52-kDa SS-A/Ro protein in neonatal lupus syndromes, systemic lupus erythematosus, and Sjogren's syndrome. (1994) (108)
Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. (1994) (107)
Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory Myopathies: Distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 Allelic Profiles and Motifs Define Clinicopathologic Groups in Caucasians (2005) (105)
Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production (2013) (105)
Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. (2006) (104)
Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. (1995) (103)
Predictors of cardiovascular damage in patients with systemic lupus erythematosus: data from LUMINA (LXVIII), a multiethnic US cohort. (2009) (103)
Epidemiology of Spondyloarthritis in North America (2011) (103)
Interferon regulatory factor-5 is genetically associated with systemic lupus erythematosus in African Americans (2008) (102)
Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort. (2008) (101)
Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance (2004) (101)
Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV) (2007) (100)
Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome. (2013) (100)
Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. (2003) (100)
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. (2013) (99)
MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus (2013) (99)
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. (2007) (99)
Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (LV). [corrected]. (2007) (98)
Novel multiplex technology for diagnostic characterization of rheumatoid arthritis (2011) (98)
Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. (1998) (96)
The changing spectrum of rheumatic disease in human immunodeficiency virus infection. (2000) (96)
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups (2012) (95)
Most African-American Patients with Rheumatoid Arthritis Do Not Have the Rheumatoid Antigenic Determinant (Epitope) (1995) (94)
Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines. (2009) (94)
Time to Renal Disease and End-Stage Renal Disease in PROFILE: A Multiethnic Lupus Cohort (2006) (94)
Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum? (1990) (93)
Does C‐Reactive Protein Predict the Long‐Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis? (2013) (93)
Low-binding alleles of Fcgamma receptor types IIA and IIIA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. (2001) (92)
The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns (2014) (92)
Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence. (2013) (90)
Analysis of autosomal genes reveals gene–sex interactions and higher total genetic risk in men with systemic lupus erythematosus (2011) (89)
Prevalence of the diffuse infiltrative lymphocytosis syndrome among human immunodeficiency virus type 1-positive outpatients. (1998) (88)
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. (2009) (88)
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. (2011) (88)
Clinical, radiographic and functional differences between juvenile-onset and adult–onset ankylosing spondylitis: results from the PSOAS cohort (2007) (88)
Axial spondyloarthritis: a new disease entity, not necessarily early ankylosing spondylitis (2012) (87)
Systemic lupus erythematosus in three ethnic groups. XI. Sources of discrepancy in perception of disease activity: a comparison of physician and patient visual analog scale scores. (2002) (87)
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). (1992) (86)
ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients (2015) (86)
Association of gastric adenocarcinoma with the HLA class II gene DQB10301. (1996) (85)
Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. (2003) (85)
Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis (2015) (85)
Whole-blood Gene Expression Profiling in Ankylosing Spondylitis Shows Upregulation of Toll-like Receptor 4 and 5 (2011) (84)
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry (2009) (84)
Alopecia areata in families: association with the HLA locus. (1999) (84)
The prevalence of inflammatory back pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009–10 (2012) (84)
HLA‐DQB1*0301 association with increased cutaneous melanoma risk (1994) (82)
Systemic lupus erythematosus: current state of the genetic hypothesis. (1984) (82)
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosis. (2013) (82)
HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis autoantibodies. (2006) (81)
Genetic associations of LYN with systemic lupus erythematosus (2009) (81)
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. (2012) (81)
What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading? (2004) (80)
The genetic basis of spondyloarthritis (2011) (80)
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. (2009) (80)
Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosus. (1991) (80)
Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma. (2002) (79)
Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. (2006) (79)
Women with ankylosing spondylitis: a review. (2008) (79)
Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events. (2005) (78)
Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis. (2008) (78)
Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis (2014) (78)
Impact of ankylosing spondylitis on work and family life: comparisons with the US population. (2008) (77)
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis (2013) (77)
Systemic Sclerosis (Scleroderma): Specific Autoantigen Genes Are Selectively Overexpressed in Scleroderma Fibroblasts1 (2001) (77)
A Novel Statistic for Genome-Wide Interaction Analysis (2010) (76)
Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII. (2009) (76)
Articular manifestations of human immunodeficiency virus infection. (2003) (76)
Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability (2006) (76)
Clinically significant valvular heart disease in systemic lupus erythematosus. (1988) (74)
The genetic basis of autoantibody production. (2006) (74)
Contrasting molecular patterns of MHC class II alleles associated with the anti-Sm and anti-RNP precipitin autoantibodies in systemic lupus erythematosus. (1993) (74)
Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival. (1993) (73)
A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. (2005) (73)
Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. (1998) (73)
Genetic variation in the CRP promoter: association with systemic lupus erythematosus. (2008) (72)
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. (2012) (72)
Rheumatologic complications of HIV infection (2006) (72)
Associations of anti-beta2-glycoprotein I autoantibodies with HLA class II alleles in three ethnic groups. (1999) (71)
Ethnicity and race and systemic sclerosis: How it affects susceptibility, severity, antibody genetics, and clinical manifestations (2003) (71)
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis (2012) (71)
Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. (2005) (70)
The Impact of Increased Body Mass Index on Systemic Lupus Erythematosus: Data From LUMINA, a Multiethnic Cohort (2007) (70)
Combined analysis of three whole genome linkage scans for Ankylosing Spondylitis. (2007) (70)
ABIN1 dysfunction as a genetic basis for lupus nephritis. (2013) (70)
ANKH variants associated with ankylosing spondylitis: gender differences (2005) (69)
Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry (2003) (69)
Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. (2011) (68)
Novel genetic markers in the 5'-flanking region of ANKH are associated with ankylosing spondylitis. (2003) (68)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case–control study (2005) (68)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage. (2004) (67)
Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. (2005) (67)
Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles. (2000) (67)
Systemic lupus erythematosus in a multiethnic US cohort: XLIII. The significance of thrombocytopenia as a prognostic factor. (2007) (67)
The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. (2014) (67)
C-reactive protein as a marker of melanoma progression. (2015) (67)
HLA-D locus associations in alopecia areata. DRw52a may confer disease resistance. (1991) (67)
HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. (2010) (66)
Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era (2009) (66)
US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV) (2010) (66)
Genetic studies of Ro (SS-A) and La (SS-B) autoantibodies in families with systemic lupus erythematosus and primary Sjögren's syndrome. (1989) (65)
The Molecular Basis of Complete Complement C4A and C4B Deficiencies in a Systemic Lupus Erythematosus Patient with Homozygous C4A and C4B Mutant Genes1 (2002) (64)
The genetics of scleroderma (systemic sclerosis) (2010) (64)
Systemic lupus erythematosus in three ethnic groups. XIX. Natural history of the accrual of the American College of Rheumatology criteria prior to the occurrence of criteria diagnosis. (2004) (64)
Familial Systemic Lupus Erythematosus: Immunogenetic Studies in Eight Families (1983) (64)
Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. (2004) (63)
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. (2012) (63)
Zidovudine improves psoriasis in human immunodeficiency virus-positive males. (1994) (62)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XL II: factors predictive of new or worsening proteinuria. (2006) (61)
Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis (2009) (61)
Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. (2014) (60)
Association of Interleukin 23 Receptor Polymorphisms with Anti-Topoisomerase-I Positivity and Pulmonary Hypertension in Systemic Sclerosis (2009) (60)
HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis. (2011) (60)
Systemic lupus erythematosus in three ethnic groups: IV. Factors associated with self‐reported functional outcome in a large cohort study (1999) (60)
Psoriasis and psoriatic arthritis associated with human immunodeficiency virus infection. (1991) (60)
Association of Vitamin D Levels With Outcome in Patients With Melanoma After Adjustment For C-Reactive Protein. (2016) (58)
Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. (2006) (58)
Antinuclear antibody-negative systemic sclerosis. (2015) (58)
PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes (2013) (58)
Genetic studies in Sjögren's syndrome and systemic lupus erythematosus. (1989) (58)
Clinical associations of anti-Smith antibodies in PROFILE: a multi-ethnic lupus cohort (2015) (57)
Allelic-Dependent Expression of an Activating Fc Receptor on B Cells Enhances Humoral Immune Responses (2013) (57)
Variation in the ICAM1–ICAM4–ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries (2012) (57)
Frequency of Axial Spondyloarthritis Diagnosis Among Patients Seen by US Rheumatologists for Evaluation of Chronic Back Pain (2016) (57)
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis (2011) (57)
The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus (2010) (56)
Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. (2005) (55)
Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis. (2009) (55)
High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. (2003) (55)
Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. (2011) (54)
The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome (1990) (54)
CCL2 in the Circulation Predicts Long‐Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts (2017) (54)
A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus (2012) (54)
Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. (2002) (53)
Genetic analyses of interferon pathway-related genes reveal multiple new loci associated with systemic lupus erythematosus. (2011) (53)
Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups. (2005) (53)
Nonmyeloablative stem cell transplant in a patient with advanced systemic sclerosis and systemic lupus erythematosus. (2004) (53)
Human immunodeficiency virus-associated atypical mycobacterial skeletal infections. (1996) (53)
Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort : LUMINA (LUI) (2008) (52)
Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort (2010) (52)
Systemic lupus erythematosus in three ethnic groups: XV prevalence and correlates of fibromyalgia (2003) (52)
The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis (2008) (51)
Evaluation of TRAF6 in a large multiancestral lupus cohort. (2012) (51)
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction (2020) (51)
Analysis of HLA-D locus alleles in alopecia areata patients and families. (1995) (51)
Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases. (2002) (50)
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis (2016) (50)
DNA analysis of HLA-DR and DQ genes in American blacks with systemic lupus erythematosus. (1989) (49)
Anti-scl-70 (2005) (49)
Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population (2009) (49)
MICA, a gene contributing strong susceptibility to ankylosing spondylitis (2013) (49)
Inflammatory bowel disease serologies in ankylosing spondylitis patients: a pilot study (2009) (48)
Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI). (2005) (48)
HLA-DRB1 genes and disease severity in rheumatoid arthritis. The MIRA Trial Group. Minocycline in Rheumatoid Arthritis. (1996) (47)
Susceptibility to Reiter's syndrome is associated with alleles of TAP genes. (1995) (47)
Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study (2012) (46)
The genetic basis of ankylosing spondylitis (2006) (46)
The HLA-DRB1*0401 Allele and the Development of Methotrexate-Induced Accelerated Rheumatoid Nodulosis: A Follow-Up Study of 79 Caucasian Patients with Rheumatoid Arthritis (2001) (46)
Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. LUpus in MInority populations: NAture vs Nurture. (2000) (45)
Major histocompatibility complex genes in systemic lupus erythematosus, Sjögren's syndrome, and polymyositis. (1988) (45)
Systemic lupus erythematosus in three ethnic groups. X. Measuring cognitive impairment with the cognitive symptoms inventory. (2002) (45)
Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis (2011) (45)
Genetic studies in the rheumatic diseases: present status and implications for the future. (2005) (45)
African–American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV) (2006) (45)
Therapy Insight: the changing spectrum of rheumatic disease in HIV infection (2008) (44)
Psychological Correlates of Self-reported Disease Activity in Ankylosing Spondylitis (2010) (44)
Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). (2006) (44)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. (2005) (44)
HLA class I and II alleles in susceptibility to ankylosing spondylitis (2018) (44)
Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression (2013) (44)
Systemic lupus erythematosus in a multiethnic US cohort: XXXIV. Deficient mannose-binding lectin exon 1 polymorphisms are associated with cerebrovascular but not with other arterial thrombotic events. (2006) (43)
Genetic Studies of Ankylosing Spondylitis in Koreans Confirm Associations with ERAP1 and 2p15 Reported in White Patients (2011) (43)
Recent studies on the genetic basis of ankylosing spondylitis (2009) (43)
Systemic lupus erythematosus in three ethnic groups. XVIII. Factors predictive of poor compliance with study visits. (2004) (42)
The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis. (1996) (42)
Economic Considerations of the Treatment of Ankylosing Spondylitis (2012) (42)
Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA): LXI. Value of C-Reactive Protein as a Marker of Disease Activity and Damage (2008) (41)
Association between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes. (2017) (41)
Genome-Wide DNA Methylation Analysis in Systemic Sclerosis Reveals Hypomethylation of IFN-Associated Genes in CD4+ and CD8+ T Cells. (2017) (41)
Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis (2019) (41)
Molecular genetics of systemic sclerosis (1993) (40)
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. (2011) (40)
Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases (2004) (40)
Novel sequence feature variant type analysis of the HLA genetic association in systemic sclerosis. (2010) (40)
Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected]. (2008) (40)
The chromosome 16q region associated with ankylosing spondylitis includes the candidate gene tumour necrosis factor receptor type 1-associated death domain (TRADD) (2009) (39)
Systemic lupus erythematosus in three ethnic groups: V. Acculturation, health‐related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA Cohort (1999) (38)
Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. (2015) (38)
Primary Sjogren's syndrome and autoimmune hemolytic anemia in sisters. A family study. (1983) (38)
A molecular analysis of the low serum deoxyribonuclease activity in lupus patients. (2001) (38)
Clinical, immunologic, and genetic features of familial systemic sclerosis. (2007) (37)
Rheumatoid nodulosis of the meninges. (1994) (37)
Malignant melanoma: relationship of the human leukocyte antigen Class II gene DQB1*0301 to disease recurrence in American Joint Committee on Cancer Stage I or II (1996) (37)
International spondyloarthritis inter-observer reliability exercise - The inspire study (2006) (37)
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort. (2011) (37)
Fcγ Receptor IIIa Single‐Nucleotide Polymorphisms and Haplotypes Affect Human IgG Binding and Are Associated With Lupus Nephritis in African Americans (2014) (36)
HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis). (1999) (36)
Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans (2018) (35)
Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort (2012) (35)
The genetic basis of spondyloarthritis (2004) (35)
Factors predictive of thrombotic events in LUMINA, a multi-ethnic cohort of SLE patients (LXXII). (2010) (35)
Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study (2017) (35)
Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus (2007) (34)
An update on the contribution of the MHC to as susceptibility (2014) (34)
Major Histocompatibility Complex Class I and Class II Alleles May Confer Susceptibility to or Protection Against Morphea: Findings From the Morphea in Adults and Children Cohort (2014) (33)
Association of Variants at 1 q 32 and STAT 3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn ’ s Disease (2010) (33)
Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. (2006) (33)
Predictors of Fatigue Severity in Early Systemic Sclerosis: A Prospective Longitudinal Study of the GENISOS Cohort (2011) (33)
Spondyloarthritis: Clinical Suspicion, Diagnosis, and Sports (2009) (32)
Association of the HLA-DRB1 with Scleroderma in Chinese Population (2014) (31)
Association of a TNAP haplotype with ankylosing spondylitis. (2007) (31)
Lupus risk variants in the PXK locus alter B-cell receptor internalization (2015) (31)
Systemic Lupus Erythematosus in a Multiethnic US Cohort (LUMINA L II): Relationship Between Vascular Events and the Use of Hormone Replacement Therapy in Postmenopausal Women (2007) (31)
Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci (2020) (30)
Ethnicity and disease severity in ankylosing spondylitis a cross-sectional analysis of three ethnic groups (2017) (30)
Soft-tissue rheumatism: diagnosis and treatment. (1997) (30)
Role of Protein Phosphatase Magnesium‐Dependent 1A and Anti–Protein Phosphatase Magnesium‐Dependent 1A Autoantibodies in Ankylosing Spondylitis (2014) (30)
Frequency and genetic background of the position 122 (Val----Ile) variant transthyretin gene in the black population. (1991) (30)
Null alleles of the fourth component of complement and HLA haplotypes in familial systemic lupus erythematosus (2004) (29)
Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort. (2008) (29)
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (2009) (29)
Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP 1 (2015) (29)
Development and validation of a case ascertainment tool for ankylosing spondylitis (2010) (28)
Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. (2009) (28)
Ankylosing spondylitis risk factors: a systematic literature review (2021) (28)
Review of Current Workforce for Rheumatology in the Countries of the Americas 2012–2015 (2016) (27)
Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: Differences in early and late disease (2013) (27)
Major histocompatibility complex class II alleles in Kawasaki syndrome--lack of consistent correlation with disease or cardiac involvement. (1992) (26)
Survival impact of autoantibodies in systemic lupus erythematosus. (1994) (26)
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (2009) (26)
Osteoarthritis in Latin America: Study of Demographic and Clinical Characteristics in 3040 Patients (2015) (26)
Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? (2012) (26)
HLA-DR2-DRB1 allele frequencies in DR2-positive black Americans with and without systemic lupus erythematosus. (1991) (25)
Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII) (2008) (25)
HLA in ankylosing spondylitis: is HLA-B27 the only MHC gene involved in disease pathogenesis? (1994) (25)
The Impact of TNF-inhibitors on radiographic progression in Ankylosing Spondylitis (2014) (24)
Using the Short Form 6D, as an overall measure of health, to predict damage accrual and mortality in patients with systemic lupus erythematosus: XLVII, results from a multiethnic US cohort. (2007) (24)
Genetic Risk Factors for Thrombosis in Systemic Lupus Erythematosus (2012) (24)
Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis (2021) (24)
Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. (2004) (24)
Gouty arthritis of the axial skeleton including the sacroiliac joints. (1987) (24)
Profiling of HLA-B Alleles for Association Studies with Ankylosing Spondylitis in the Chinese Population (2013) (23)
Biologics, spondylitis and COVID-19 (2020) (23)
Presence of the human leukocyte antigen class II geneDRB1*1101 predicts interferon γ levels and disease recurrence in melanoma patients (2002) (22)
Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis. (2005) (22)
Pneumatosis cystoides intestinalis and benign pneumoperitoneum in a patient with antinuclear antibody negative systemic lupus erythematosus. (1988) (22)
C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus (2006) (22)
A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus (2018) (22)
Prevalence of Chronic Axial Pain, Inflammatory Back Pain, and Spondyloarthritis in Diagnosed Psoriasis (2015) (21)
Analysis of HLA-B15 and HLA-B27 in spondyloarthritis with peripheral and axial clinical patterns (2015) (21)
Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Results from LUMINA (LXXVIII), a multiethnic, multicenter US cohort (2019) (21)
The Non-Muscle Myosin Heavy Chain 9 Gene (MYH9) Is Not Associated with Lupus Nephritis in African Americans (2010) (21)
Erratum: Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) (Clinical and Experimental Rheumatology (2008) vol. 26 (268-274)) (2008) (20)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXXI: factors associated with patients being lost to follow-up (2006) (20)
Gene-level association analysis of systemic sclerosis: A comparison of African-Americans and White populations (2018) (20)
Clinical patterns and characteristics of ankylosing spondylitis in China (2017) (20)
HLA class II and HLA-B27 oligotyping in two Siberian native population groups. (1995) (20)
Ankylosing spondylitis and the spondyloarthropathies (2013) (20)
Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual. (2007) (19)
Relationship between adherence to study and clinic visits in systemic lupus erythematosus patients: data from the LUMINA cohort (2004) (19)
Anti‐P Antibodies and Neuropsychiatric Lupus Erythematosus (1997) (19)
Familial polyarteritis nodosa: a serologic and immunogenetic analysis. (1989) (18)
A Polymorphism in TLR2 Is Associated With Arterial Thrombosis in a Multiethnic Population of Patients With Systemic Lupus Erythematosus (2014) (18)
Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis (2020) (18)
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity (2006) (18)
Effects of statins on proinflammatory/prothrombotic biomarkers and on disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort. (2014) (18)
Association of a 9.2-kilobase Pvu II class I major histocompatibility complex restriction fragment length polymorphism with ankylosing spondylitis. (1987) (18)
Opioid Analgesic Use in Patients with Ankylosing Spondylitis: An Analysis of the Prospective Study of Outcomes in an Ankylosing Spondylitis Cohort (2017) (17)
Lack of association of matrix metalloproteinase 3 (MMP3) genotypes with ankylosing spondylitis susceptibility and severity. (2005) (17)
Systemic lupus erythematosus in three ethnic groups. VIII. Lack of association of glutathione S-transferase null alleles with disease manifestations. (2001) (16)
Epidemiology of Ankylosing Spondylitis: IGAS 2009 (2010) (16)
DNA analysis of HLA-DR, DQ, and DP alleles in children with polyarticular juvenile rheumatoid arthritis. (1992) (15)
Impact of immigration on the clinical expression of systemic lupus erythematosus: a comparative study of Hispanic patients residing in the USA and Mexico. (2009) (15)
2 The immunogenetics of the seronegative spondyloarthropathies (1998) (15)
Perceived Functioning Has Ethnic-specific Associations in Systemic Sclerosis: Another Dimension of Personalized Medicine (2009) (15)
Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis. (2009) (15)
DNA analysis of HLA-DR, DQ and DP genes in pauciarticular juvenile rheumatoid arthritis. (1991) (14)
The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with ankylosing spondylitis. (2011) (14)
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (14)
Functional Limitations Due to Axial and Peripheral Joint Impairments in Patients With Ankylosing Spondylitis: Are Focused Measures More Informative? (2013) (14)
Cauda Equina Syndrome in Ankylosing Spondylitis: Challenges in Diagnosis, Management, and Pathogenesis (2019) (14)
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA (2014) (14)
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic (2015) (14)
Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic lupus erythematosus in Asians. (2013) (14)
SLE in three ethnic groups XIII. The ‘weighted’ criteria as predictors of damage (2002) (14)
Autoantibodies to a nucleolar RNA helicase protein in patients with connective tissue diseases. (1997) (14)
Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production (2016) (14)
HLA associations of anti-beta2 glycoprotein I response in a Greek cohort with antiphospholipid syndrome and meta-analysis of four ethnic groups. (1999) (14)
Brief Report: HLA–DRB1, DQA1, and DQB1 in Juvenile‐Onset Systemic Sclerosis (2016) (14)
Systemic lupus erythematosus in three ethnic groups. IV. Factors associated with self-reported functional outcome in a large cohort study. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. (1999) (14)
Identification of HLA-DQα and -DRβ residues associated with susceptibility and protection to epithelial ovarian cancer (2005) (13)
The interplay of nature versus nurture in predisposition to the rheumatic diseases. (1993) (13)
New Population‐Based Reference Values for Spinal Mobility Measures Based on the 2009–2010 National Health and Nutrition Examination Survey (2014) (13)
Frequencies of scleroderma‐realted autoantibodies in patients meeting the American Collage of Rheumatology criteria for system sclerosis:replay (1993) (13)
Identification of HLA-DQα and -DRβ residues associated with susceptibility and protection to epithelial ovarian cancer (2005) (13)
Safety and Efficacy of Intravenous Golimumab in Adults with Ankylosing Spondylitis: Results through 1 Year of the GO-ALIVE Study (2019) (12)
Bullous lupus erythematosus rash worsened by Dapsone. (1984) (12)
Genetic associations of LYN with systemic lupus erythematosus (2010) (12)
The Effect of HLA-B27 on Susceptibility and Severity of COVID-19 (2020) (12)
Erratum: The impact of increased body mass index on systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort (LUMINA XLVI) (Journal of Clinical Rheumatology (2007) 3, (128-133)) (2007) (11)
Harmonization, data management, and statistical issues related to prospective multicenter studies in Ankylosing spondylitis (AS): Experience from the Prospective Study Of Ankylosing Spondylitis (PSOAS) cohort (2018) (11)
Poly(ADP)-ribose polymerase and susceptibility to systemic lupus erythematosus and primary antiphospholipid syndrome: comment on the article by Delrieu et al. (2000) (11)
Genetic association of non-MHC region with ankylosing spondylitis in a Chinese population (2018) (11)
The human leukocyte antigen TAP2 gene defines the centromeric limit of melanoma susceptibility on chromosome 6p. (1996) (10)
Effect of ethnicity on disease activity in systemic lupus erythematosus. (2005) (10)
A multiple imputation method based on weighted quantile regression models for longitudinal censored biomarker data with missing values at early visits (2018) (10)
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis (2019) (10)
A family-based genome-wide association study reveals an association of spondyloarthritis with MAPK14 (2015) (10)
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years (2021) (10)
Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in disease manifestations, course, and outcome. (2006) (10)
Reliability and Validity of Patient-reported Outcomes Measurement Information System Short Forms in Ankylosing Spondylitis (2019) (10)
HLA class II alleles and autoantibodies in Bulgarians with systemic lupus erythematosus. (1995) (10)
The immunogenetics of the seronegative spondyloarthropathies. (1998) (10)
Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus. (2015) (10)
Smoking quantity determines disease activity and function in Chinese patients with ankylosing spondylitis (2018) (10)
Systemic lupus erythematosus in three ethnic groups. V. Acculturation, health-related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA cohort. LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture. (1999) (10)
Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study (2017) (10)
Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry (2013) (10)
Association between Copy Number Variations HLA-DQA1 and Ankylosing Spondylitis in Chinese Han population (2013) (10)
Gene and Pathway-Based Analysis: Second Wave of Genome-wide Association Studies (2008) (9)
A registry of ankylosing spondylitis registries and prospects for global interfacing (2013) (9)
Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes (2015) (9)
Rapid direct determination of HLA-DQB1 * 0301 in the whole blood of normal individuals and cancer patients by specific polymerase chain reaction amplification. (1996) (9)
Achievement of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Criteria for Systemic Lupus Erythematosus and Amount of Damage Accrual: Results From a Multiethnic Multicenter Cohort (2021) (8)
Association of HLA-DOB1*0301 with malignant melanoma. (1996) (8)
Il-23r is a major determinant of ankylosing spondylitis risk - The tasc study (2007) (8)
Discontinuation rate and factors predictive of the use of hydroxychloroquine in LUMINA, a multiethnic US cohort (LUMINA XL) (2006) (8)
IRF 5 polymorphism predicts prognosis in patients with systemic sclerosis (2011) (8)
Report on the First PANLAR Rheumatology Review Course Rheumatoid Arthritis: Challenges and Solutions in Latin America (2015) (7)
Genetics of ankylosing spondylitis. (2002) (7)
Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients (2022) (7)
The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI score (2020) (7)
A dimorphic Alu Sb-like insertion in COL3A1 is ethnic-specific (1996) (7)
Identification of HLA-DQalpha and -DRbeta residues associated with susceptibility and protection to epithelial ovarian cancer. (2005) (7)
Clinical Features of ANA‐Positive and ANA‐Negative Patients with Fibromyalgia (1998) (7)
Genomewide association study in Ankylosing spondylitis identifies major Non-MHC genetic determinants of disease susceptibility (2008) (7)
Patients Who Do Not Fulfill the 2019 EULAR/ACR Criteria for Systemic Lupus Erythematosus Accrue Less Damage. (2020) (7)
A polymorphism within interleukin-21 receptor (IL21R) confers risk for systemic lupus erythematosus and is associated with malar rash in lupus patients (49.17) (2009) (6)
Restriction fragment length polymorphism analysis in ankylosing spondylitis. (1988) (6)
Entheses and Bones in Spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN) (2009) (6)
OP0110 Treat-To-Target Recommendations for Spondyloarthritis, Including Ankylosing Spondylitis and Psoriatic Arthritis: A Consensus of an International Task Force (2013) (6)
Systemic Lupus Erythematosus in a Multiethnic US Cohort, LUMINA (XLIX): Preliminary Evaluation of the Impact of Statins on Disease Activity (2008) (6)
2007 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). (2008) (6)
OP0198 Combined effects of tumour necrosis factor inhibitors and nsaids on radiographic progression in ankylosing spondylitis (2018) (6)
THU0065 Prevalence of Axial Spondyloarthritis among Undiagnosed Chronic Back Pain Patients in the United States (2014) (6)
Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). (2006) (6)
Associations of Multiple NOTCH4 Exonic Variants with Systemic Sclerosis (2018) (5)
Baseline characteristics of a multiethnic lupus cohort: PROFILE (2002) (5)
Factors associated with disease expression patterns in systemic lupus erythematosus patients: results from LUMINA (LXXVII), a multiethnic US cohort (2017) (5)
The MHC Class II Haplotype HLA–DRB1*0801/DQA1*0401/DQB1*0402 Is Associated With Acute Anterior Uveitis (2005) (5)
2006 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). (2007) (5)
4 – MHC CLASS II AND NON-MHC GENES IN THE PATHOGENESIS OF SYSTEMIC LUPUS ERYTHEMATOSUS (2004) (5)
Predictors of Hand Contracture in Early Systemic Sclerosis and the Effect on Function: A Prospective Study of the GENISOS Cohort (2019) (5)
Imputation-based analysis of MICA alleles in the susceptibility to ankylosing spondylitis (2019) (4)
Spondyloarthropathies: EULAR recommendations reflect advances in imaging (2015) (4)
HLA restriction fragment length polymorphisms associated with insulin-dependent diabetes mellitus and the seronegative spondyloarthropathies (1985) (4)
C4A gene deletion and HLA associations in black americans with systemic lupus erythematosus (SLE) (1988) (4)
Analysis of restriction fragment length polymorphisms in rheumatic diseases. (1987) (4)
Inspire lateral flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis (SpA) (2006) (4)
The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial (2020) (4)
Validation of the Ankylosing Spondylitis Quality of Life assessment tool in patients with non-radiographic axial spondyloarthritis (2020) (4)
113 – Rheumatic Manifestations of Human Immunodeficiency Virus Infection (2013) (4)
Identifying Trajectories of Radiographic Spinal Disease in Ankylosing Spondylitis: A 15-year follow up study of the PSOAS Cohort. (2021) (4)
Letter to the Editor (2005) (4)
Systemic lupus erythematosus in the setting of HIV-1 infection: a longitudinal analysis (2020) (4)
The Genetic Basis of Spondyloarthritis: SPARTAN/IGAS 2009 (2010) (4)
Genetics of Axial Spondyloarthritis (2019) (4)
Development of a Health Index in Patients With Ankylosing Spondylitis (ASAS HI)-Final Result of a Global Initiative Based On the International Classification of Functioning, Disability and Health (ICF) Guided By Assessment of Spondyloarthritis International Society (ASAS). (2013) (4)
The pathogenesis of Ankylosing spondylitis (2006) (4)
The relationship between blood IL‐12p40 level and melanoma progression (2015) (4)
Molecular basis of complete C4 deficiency in a SLE patient with four mutant genes: A 2- BP insertion at exon 29 in C4A and A 1-BP deletion at exon 13 in C4B (2000) (4)
Missense mutations in the MLKL ‘brace’ region lead to lethal neonatal inflammation in mice and are present in high frequency in humans (2019) (4)
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort (2021) (3)
Prologue: 2009 Joint Meeting of Spondyloarthritis Research and Therapy Network (SPARTAN) and International Genetics of Ankylosing Spondylitis (IGAS) (2010) (3)
FRI0468 Socioeconomic status predicts radiographic progression in ankylosing spondylitis (2013) (3)
The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment (2021) (3)
HLA-B27 is associated with reduced disease activity in axial spondyloarthritis (2021) (3)
Cardiovascular Risk Scores in Axial Spondyloarthritis Versus the General Population: A Cross-sectional Study (2020) (3)
Biomarkers in axial spondyloarthritis and low back pain: a comprehensive review (2021) (3)
Molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. (1990) (3)
The changing profile of ankylosing spondylitis in the biologic era (2020) (3)
Immunogenetics of systemic autoimmune diseases. (1991) (3)
Klinefelter’s Syndrome, 47,XXY, in Male Systemic Lupus Erythematosus Supports a Gene Dose Effect from the X Chromosome (2011) (2)
A latent class based imputation method under Bayesian quantile regression framework using asymmetric Laplace distribution for longitudinal medication usage data with intermittent missing values (2019) (2)
Increased frequency of the deletion allele of the ACE gene in African-Americans compared to Caucasians (1996) (2)
Biological treatment usage in patients with HIV and rheumatic disease, 2003–2021: long-term safety and follow-up (2022) (2)
Cardiovascular Disease Is Associated With Worse Functional Outcomes In Ankylosing Spondylitis (2013) (2)
Mmp1 Polymorphisms Are Associated with Severity of Radiographic Measures of Ankylosing Spondylitis (2011) (2)
A rare variant of RNF123 in familial ankylosing spondylitis causes dysfunction of osteoclast formation. (2019) (2)
6.2-09 “Trans” or “cis” combinations of HLA-DQα2 or α6/HLA-DQβ2 or β6 chain genes promote the RO(SS-A)/LA(SS-B) autoantibody responses (1989) (2)
Adalimumab improves physical functioning and work productivity in ankylosing spondylitis (AS) patients: Results from ATLAS. (2006) (2)
A Genomewide Association Study of Anterior Uveiti (2012) (2)
Abstract 5568: Elevated interleukin-12 is a plasma marker of poor prognosis in stage III melanoma patients (2008) (2)
The Interleukin-23 Receptor Is a New Susceptibility Gene for Acute Anterior Uveitis (2008) (2)
POS0918 EVALUATION OF SPINAL RADIOGRAPHIC PROGRESSION IN PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS RECEIVING IXEKIZUMAB THERAPY OVER 2 YEARS (2021) (2)
Development of an environmental contextual factor item set relevant to global functioning and health in patients with axial Spondyloarthritis. (2021) (2)
Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time (2020) (2)
Correction: Association of Interleukin 23 Receptor Polymorphisms with Anti-topoisomerase-I Positivity and Pulmonary Hypertension in Systemic Sclerosis (2010) (2)
Disease Activity and Damage are not Associated with Increased Levels of Fatigue in Systemic Lupus Erythematosus Patients from LUMINA LXVII, a Multiethnic Cohort (2011) (2)
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial. (2020) (2)
Single‐cell analysis reveals innate immunity dynamics in ankylosing spondylitis (2021) (2)
Factors associated with anti-TNF treatment in a longitudinally followed ankylosing spondylitis (AS) cohort (2015) (2)
HLA-DRB1 alleles in a Caucasian population from Houston, USA (2004) (2)
Better outcomes in ankylosing spondylitis: the synergistic association between exercise and tumor necrosis factor inhibitors (2014) (2)
Longitudinal associations between depressive symptoms and clinical factors in ankylosing spondylitis patients: analysis from an observational cohort (2020) (2)
Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness. (2017) (2)
The Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI) is Associated with Damage In Systemic Lupus Erythematosus Patients. (2022) (1)
Frequency of the Position 122 (VAL→ILE) Variant Transthyretin Gene in Blacks Without Amyloidosis (1991) (1)
Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study (2020) (1)
Erratum: Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort (Rheumatology (2008) vol. 47 (362-367) 10.1093/rheumatology/kem371) (2008) (1)
HLA class II alleles predict recurrence and pattern of failure in early-stage melanoma patients (2007) (1)
ASSOCIATION OF HLA-DQB1*0301 WITH MALIGNANT MELANOMA. AUTHOR'S REPLY (1996) (1)
Diagnostic capacity of genetic tests in Ankylosing spondylitis can exceed MRI scanning (2008) (1)
Gender differences in ankylosing spondylitis: Men derive greater benefit from tumor necrosis factor alpha inhibitors (2015) (1)
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction (2020) (1)
Restriction fragment length polymorphism (RFLP) analysis of class II MHC genes in SLE: Associations with clinical and autoantibody subsets in caucasians (1988) (1)
Value of Isolated IgA anti-β2GPI Positivity in the Diagnosis of the Antiphospholipid Syndrome (2014) (1)
Human leucocyte antigen typing in rheumatoid arthritis/polymyositis overlap syndrome. (1995) (1)
The molecular genetics of systemic lupus erythematosus and Sjögren's syndrome. (1992) (1)
Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: comment on the article by Frostegård et al. (2006) (1)
Correction: Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease (2011) (1)
OP0214 Development of a Health Index in Patients with Ankylosing Spondylitis (ASAS HI) – Final Result of a Global Initiative Based on the ICF Guided by ASAS (2013) (1)
Plasma endogenous enkephalin levels in early systemic sclerosis: clinical and laboratory associations. (2010) (1)
Chapter 113 – Rheumatic Manifestations of Human Immunodeficiency Virus Infection (2017) (1)
Chapter 17 – Spectrum of Reactive Arthritis (2007) (1)
Molecular genetics of systemic sclerosis. (1995) (1)
Discussion: Why do we test multiple traits in genetic association studies? (2009) (1)
SAT0380 Nsaids Modify The Effect of Tumor Necrosis Factor Inhibitors on New Bone Formation in Ankylosing Spondylitis (2016) (1)
Association of a restriction fragment length polymorphism with seronegative spondyloarthropathies (1986) (1)
Meta-analysis in ankylosing spondylitis (AS) - Genomewide linkage map including 589 affected sibling pairs. (2005) (1)
Prologue: 2010 Spondyloarthritis Research and Therapy Network (SPARTAN) Annual Research and Education Meeting (2011) (1)
HLA-B27 subtypes among the Chukotka Native groups. (1995) (1)
Clinical Utility of Common Genetic Variants for Ankylosing Spondylitis (2011) (1)
Shared HLA Class I and II Alleles in Susceptibility to Ankylosing Spondylitis Among Three Ethnic Groups. (2014) (1)
Efficacy and Safety of Intravenous Golimumab in Ankylosing Spondylitis Patients With Early and Late Disease Through One Year of the GO-ALIVE Study (2022) (1)
Restriction fragment length polymorphism (RFLP) analysis of class II MHC genes in SLE: Lack of disease association in american blacks (1988) (1)
List of Contributors (2019) (0)
A genomewide association study of anterior uveitis (2012) (0)
Reply (2015) (0)
Correction: Stoll et al. Impact of HLA-B27 and Disease Status on the Gut Microbiome of the Offspring of Ankylosing Spondylitis Patients. Children 2022, 9, 569 (2022) (0)
S.12.1 Is H1N1 influenza vaccine safe and effective in patients with SSc (2012) (0)
Lack of association of class II MHC alleles with Kawasaki syndrome (1992) (0)
HIV infection with allergic and rheumatic diseases (2018) (0)
Associations of Changes of Radiographic Disease and Spinal Mobility Measures in Ankylosing Spondylitis (2017) (0)
POS0902 EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN ANKYLOSING SPONDYLITIS PATIENTS WITH EARLY VS LATE DISEASE THROUGH WEEK 52 OF GO-ALIVE STUDY (2021) (0)
The Journal of Rheumatology SpondylitisPsychological Correlates of Self-reported Disease Activity in Ankylosing (2010) (0)
FRI0398 Pharmacologic Therapy and Radiographic Progression in Ankylosing Spondylitis: A Growing Controversy (2016) (0)
The Genetic Basis of Spondyloarthritis: SPARTAN/IGAS 2009 (2011) (0)
Whole-bloodGeneExpressionProfilingin AnkylosingSpondylitisShowsUpregulation ofToll-likeReceptor4and5 (2010) (0)
Primary Sjögren's Syndrome and Other Autoimmune Diseases in Families (2020) (0)
P194 Response to ixekizumab by C-reactive protein level in patients with aadiographic axial spondyloarthritis: results from the COAST-V (biological-naïve) and COAST-W (TNF-α inhibitor-experienced) trials at 52 weeks (2021) (0)
Statins Reduce Disease Activity (SLAM-R) and Organ Damage Accrual (SLICC Damage Index, SDI) Scores in SLE Patients From A Multi-Center, Multi-Ethnic, US Cohort. (2009) (0)
The haplotype HLA-B*0700, DRB1*1501, DQA1*0102, DQB1*0602 augments the risk for the development of AS in addition to HLA-B27 (2004) (0)
Chronic inflammatory back pain commencing late in life: a neglected concept (2022) (0)
AS and a 9.2 kb Pvu II class I HLA DNA restriction fragment. (1989) (0)
HLA class II genotype in causians with progressive systemic sclerosis (PSS): Associations with autoantibody subsets (1991) (0)
Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (Genes and Immunity (2009) vol. 10 (457-469) 10.1038/gene.2009.27) (2009) (0)
SAT0400 Clinical Factors Impacting Statin Usage in A Longitudinal Ankylosing Spondylitis Cohort (2016) (0)
LONG-TERM SAFETY AND EFFICACY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS : 96-WEEK OUTCOMES OF THE RAPID-AXSPA TRIAL (2014) (0)
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis (2023) (0)
Overexpressed in Scleroderma Fibroblasts Autoantigen Genes Are Selectively Systemic Sclerosis (Scleroderma): Specific (2001) (0)
Immunochip Analysis Identifies New Susceptibility Loci For Systemic Sclerosis: Implications For Pathogenesis (2013) (0)
A Genetic Model for IRF5, Autoantibodies, and Interferon Alpha in Human Lupus Pathogenesis (2009) (0)
Health-Related Quality of Life in Adults with Adolescent- and Adult-onset Systemic Lupus Erythematosus: A Longitudinal Study of a Multiethnic US Cohort (LUMINA LXXXIV). (2022) (0)
SNPs in VKORC1 are Risk Factors for Systemic Lupus Erythematosus in Asians: Genetic risk factors for Lupus (2013) (0)
IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis (2019) (0)
Meta-analysis of Immunochip data of four autoimmune diseases reveals novel single-disease and cross-phenotype associations (2018) (0)
Erythrocyte CR1 levels do not correlate with disease activity in hispanic SLE patients (2000) (0)
IL-1 gene family members are associated with ankylosing spondylitis in both Caucasian and Asian populations: a meta-analysis (2006) (0)
Minimal Impact of the COVID‐19 Pandemic on Disease Activity and Health‐Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open‐Label Extension Study (2022) (0)
Editorial comment: HIV-1 infection and the rheumatic diseases--new issues, new challenges, same old disparities. (2004) (0)
Environmental Risks for Spondyloarthropathies. (2022) (0)
S.11.1 Influence of digital ulcer healing on disability and daily activity limitations in SSc (2012) (0)
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease (2020) (0)
The faecal microbiota is distinct in HLA-B27+ ankylosing spondylitis patients versus HLA-B27+ healthy controls. (2022) (0)
Interaction of a region on chromosome 11q23 and the HLA-DPB1 locus influences susceptibility to ankylosing spondylitis (AS) (2004) (0)
The Accuracy of Self–Reporting Acute Anterior Uveitis (2005) (0)
HLA-DRB1*0101 and DRB1*1501 but not HLA-B60(B*4001) Contribution to susceptability to Ankylosing Spondylitis (AS (2002) (0)
Factors Associated With Knee Osteoarthritis in an Outpatient HIV-1 Clinic Setting (2021) (0)
Infection and Spondyloarthritis (2019) (0)
Analysis of HLA-DR and DQ subtypes associated with the Ro (SS-A) and la (SS-B) autoantibodies (1988) (0)
Repeated Spinal Mobility Measures and Their Association With Radiographic Damage in Ankylosing Spondylitis (2021) (0)
The Interleukin Receptor-1Antagonist (IL-1Ra) Gene is implicated in predisposition to Ankylosing Spondylitis (2002) (0)
The Major Histocompatibility Complex and Reactive Arthritis (2019) (0)
Definite evidence of at least one other major histocompatibility antigen apart from HLA B27 in the susceptability of Anklylosing Spondylitis (2002) (0)
Response to “Comment on the Recommendations by Ward et al for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis” by Akkoc and Khan (2016) (0)
Error in Tables 3, 5, and 6 and Text in Article by Jacobe et al (Arthritis Rheumatol, November 2014) (2015) (0)
A genome wide scan identifies 3 loci predisposing to acute anterior uveitis including one locus unassociated with ankylosing spondylitis (2004) (0)
Opiate Use In Patients With Ankylosing Spondylitis (2013) (0)
Candidate Gene SNP Analysis Within the Locus on Chromosome 9p With Linkage to Acute Anterior Uveitis (2005) (0)
Reply (2016) (0)
THU0390 GENETIC STUDY OF MEDICAL IMAGE PROGRESSION IN A CHINESE AS POPULATION FOR SIX MONTHS’ FOLLOW-UP (2019) (0)
Chapter 3 – The Pathogenesis of Ankylosing Spondylitis (2006) (0)
Sclerosis Anti-Topoisomerase-I Positivity and Pulmonary Hypertension in Systemic Association of Interleukin 23 Receptor Polymorphisms with MAYES and (2009) (0)
Gender Bias in the Inheritance of Ankylosing Spondylitis (2017) (0)
Erratum: Genetic associations of LYN with systemic lupus erythematosus (Genes and Immunity (2009) 10 (397-403) DOI: 10.1038/gene.2009.19) (2010) (0)
Fine mapping of candidate susceptibility regions in ankylosing spondylitis on chromosome 11q (2003) (0)
Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis (2022) (0)
A Polymorphism in the 5` non-coding Region of ANKH is Significantly Linked to and Associated with Ankylosing Spondylitis in North American families (2003) (0)
Association between nonsteroidal anti-inflammatory drugs and uveitis recurrence in ankylosing spondylitis patients (2018) (0)
CS-16 Remission and low disease activity state (LDAS) are protective of intermediate and long-term outcomes in SLE patients. Data from a multi-ethnic, multi-center US cohort (2018) (0)
Fine mapping of a candidate susceptibility region on chromosome 11 in ankylosing spondylitis (2003) (0)
Reply (2016) (0)
POS0904 FACTORS ASSOCIATED WITH SWITCHING FROM ONE ANTI-TNF AGENT TO ANOTHER ANTI-TNF, OR IL17 AGENT IN PATIENT WITH ANKYLOSING SPONDYLITIS (2021) (0)
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’ (2021) (0)
Predictors of depression severity in ankylosing spondylitis (2015) (0)
The association of endoplasmic reticulum aminopeptidase 2 (ERAP2) with ankylosing spondylitis (AS) was recently described in the large International Genetics of AS Consortium (2015) (0)
A7.25 Gene-Gene Interactions in Interferon Pathway Gene Polymorphisms in European and American Scleroderma Cohorts (2013) (0)
Familial Acute Anterior Uveitis: An HLA Analysis (2003) (0)
Update on the Treatment of Systemic Lupus Erythematosus (2006) (0)
Correction to: The IgG galactosylation ratio is higher in spondyloarthritis patients and associated with the MRI score (2020) (0)
HLA-DPB1 alleles and the systemic connective tissue diseases: A question of disease relevance (1991) (0)
Reply: To PMID 25154344. (2015) (0)
Genetic Associations In Anterior Uveitis Implicate T-Cell Co-Stimulation and Other Immune Pathways (2013) (0)
Response to Akkoc and Khan (2015) (0)
OP0251 Development of a health index to assess the burden of disease in patients with ankylosing spondylitis – first steps of a global initiative based on the ICF guided by ASAS (2013) (0)
P289 – HLA class II alleles and DR-DQ haplotypes in native inhabitants of Chukotka (1996) (0)
Improved physical functioning and work productivity in ankylosing spondylitis (AS) patients who were treated with adalimumab-ATLAS trial results (2007) (0)
List of Contributors (2019) (0)
Exome-wide association analysis suggests LRP2BP as a susceptibility gene for endothelial injury in systemic sclerosis in Han Chinese population. (2020) (0)
The Identification of New Genetic Associations for Acute Anterior Uveitis in a Genomewide Scan Comparison of Ankylosing Spondylitis Cases With vs. Without Uveitis (2010) (0)
OP0203 A Family-Based Genome-Wide Association Study Reveals an Association of Spondyloarthritis with MAPK14 (2015) (0)
Correction: Association of Variants at 1q32 and STAT3 with Ankylosing Spondylitis Suggests Genetic Overlap with Crohn's Disease (2011) (0)
A genetic marker in the 5 ' non-coding region of ankH is associated with ankylosing spondylitis (2002) (0)
Systemic lupus erythematosus. Part I: A clinical and diagnostic challenge (1990) (0)
Clinical Factors Impacting Opiate Usage in a Longitudinal Ankylosing Spondylitis Cohort (2016) (0)
The effect of acculturation on health-related attitudes, behavior and outcome in Hispanic SLE patients (1996) (0)
The global miRNA whole blood profile of ankylosing spondylitis (2015) (0)
Evidence for a second major histocompatibility complex (MHC) gene in predisposition to Familial ankylosing spondylitis (AS) (2001) (0)
Dry eye in Diffuse Infiltrating Lymphocytosis Syndrome (DILS) (1996) (0)
Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis (2011) (0)
Genetic associations of non-MHC susceptibility loci with systemic sclerosis in a Han Chinese population. (2021) (0)
Association of Systemic Lupus International Collaborating Clinics Frailty Index With Damage in Systemic Lupus Erythematosus Patients: Results From a Multiethnic, Multicenter US Cohort of Patients With Lupus (2023) (0)
A genome-wide scan in familial ankylosing spondylitis susceptibility (2003) (0)
6.2-13 Analysis of restriction fragment length polymorphism of class II MHC in pauciarticular juvenile rheumatoid arthriris (1989) (0)
Systemic lupus erythematosus Part II: Issues in long-term management and pregnancy (1990) (0)
The large majority of African-American patients with seropositive RA do not possess the rheumatoid epitope (1994) (0)
Why Do Some Patients Have Severe Sacroiliac Disease But No Syndesmophytes in Ankylosing Spondylitis? Data From a Nested Case-Control Study (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John D. Reveille?

John D. Reveille is affiliated with the following schools:

University of Texas Health Science Center at Houston

John D. Reveille's Academic­Influence.com Rankings

Why Is John D. Reveille Influential?

John D. Reveille's Published Works

Published Works

What Schools Are Affiliated With John D. Reveille?

John D. Reveille's AcademicInfluence.com Rankings